» Articles » PMID: 1940479

Reduction of Oropharyngeal Carriage of Haemophilus Influenzae Type B (Hib) in Children Immunized with an Hib Conjugate Vaccine

Overview
Journal J Infect Dis
Date 1991 Nov 1
PMID 1940479
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

The oropharyngeal carriage of Haemophilus influenzae type b (Hib) was studied among 725 healthy 3-year-old children who had or had not been immunized with an Hib conjugate vaccine. Oropharyngeal swabs were collected during the childrens' well-child visit to their local child health center. Fourteen (3.5%) of the 398 unvaccinated children were oropharyngeal carriers of Hib, whereas none of the 327 children who had received Hib conjugate vaccine carried Hib (P less than .001). Carriage rates of non-type b H. influenzae (19%) or Streptococcus pneumoniae (18%) were the same irrespective of the Hib vaccination status of the children. Thus Hib conjugate vaccine, unlike Hib polysaccharide vaccine, seems to be able to prevent oropharyngeal colonization by Hib.

Citing Articles

Vaccination of Rabbits with a Cholera Conjugate Vaccine Comprising O-Specific Polysaccharide and a Recombinant Fragment of Tetanus Toxin Heavy Chain Induces Protective Immune Responses against Vibrio cholerae O1.

Kelly M, Jeon S, Yun J, Lee B, Park M, Whang Y Am J Trop Med Hyg. 2023; 109(5):1122-1128.

PMID: 37783453 PMC: 10622467. DOI: 10.4269/ajtmh.23-0259.


Lipidation of Antigens P6 and OMP26 Improves Immunogenicity and Protection against Nasopharyngeal Colonization and Ear Infection.

Kaur R, Pichichero M Infect Immun. 2022; 90(5):e0067821.

PMID: 35435727 PMC: 9119059. DOI: 10.1128/iai.00678-21.


Induction of Susceptibility to Disseminated Infection with IgA1 Protease-Producing Encapsulated Pathogens Streptococcus pneumoniae, Haemophilus influenzae Type b, and Neisseria meningitidis.

Kilian M, Husby S, Andersen J, Moldoveanu Z, Skov Sorensen U, Reinholdt J mBio. 2022; 13(3):e0055022.

PMID: 35420467 PMC: 9239265. DOI: 10.1128/mbio.00550-22.


Scalable production and immunogenicity of a cholera conjugate vaccine.

Jeon S, Kelly M, Yun J, Lee B, Park M, Whang Y Vaccine. 2021; 39(47):6936-6946.

PMID: 34716040 PMC: 8609181. DOI: 10.1016/j.vaccine.2021.10.005.


Glycoconjugate Vaccines for Prevention of Type b Diseases.

Khatuntseva E, Nifantiev N Russ J Bioorg Chem. 2021; 47(1):26-52.

PMID: 33776394 PMC: 7980804. DOI: 10.1134/S1068162021010106.